---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-204983"
form_type: "8-K"
ticker: "RPRX"
cik: "0001802768"
company_name: "Royalty Pharma plc"
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:31:16.457430+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Royalty Pharma prices $2B senior notes in three tranches: 2031, 2035, 2055

## Summary
- $600M 4.450% notes due 2031, $900M 5.200% notes due 2035, $500M 5.950% notes due 2055.
- Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd and RP Manager LLC.
- Issuance closed September 16, 2025; interest payments begin March 25, 2026.
- Underwriters include BofA, Goldman Sachs, J.P. Morgan, Morgan Stanley, and TD Securities.

## SEC filing metadata
- accession: 0001193125-25-204983
- form_type: 8-K
- ticker: RPRX
- cik: 0001802768
- company_name: Royalty Pharma plc
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1802768/000119312525204983/0001193125-25-204983-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1802768/000119312525204983/d58607d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-204983
- JSON: https://secwatch.observer/filing/0001193125-25-204983.json
- Plain text: https://secwatch.observer/filing/0001193125-25-204983.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.